Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound)
Each COA documents peptide identity by HPLC and/or mass spectrometry, verified purity, and, where applicable, sterility and endotoxin testing, plus recommended storage conditions
Here's an honest look at how it works, what the research suggests, and how it's used only under medical supervision
Understanding GLP-1 Injection Weight Loss Programs A GLP-1 injection weight loss program typically involves much more than receiving a weekly injection
The practical implication of this triple mechanism is that your body is going through a significant metabolic shift during Retatrutide use
Taking collagen peptides with vitamin C supports the building blocks BPC-157 helps organize